Rheumatoid Arthritis

Rheumatoid Arthritis Resource Center
The Great Debate at ACR Convergence 2020 is: Janus Kinase Inhibitors Should/Should Not Be Used Before Biologics After Methotrexate Failure in RA. No need to hang in suspense. In this resource center, you’ll get the pros and cons, and highlights from other important sessions on rheumatoid arthritis (RA). Plus, you can explore our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of RA.
VIEW

Predicting the Future: Prognostication in Rheumatoid Arthritis

July 19, 2022 • By Jason Liebowitz, MD

Not Your Average Case: Difficult-to-Treat Rheumatoid Arthritis

July 15, 2022 • By Jason Liebowitz, MD

Clinical Guidance & Recommendation Updates for Vasculitis, axSpA & More

July 15, 2022 • By Jason Liebowitz, MD

Challenges in Reproductive Health in Rheumatic Disease

July 11, 2022 • By Keri Losavio & Julie Nusbaum, MD

Gene Profiling May Predict Treatment Response in Refractory Rheumatoid Arthritis

June 7, 2022 • By Marilynn Larkin

Researchers Should Use ACR/EULAR Definition of RA Remission in Clinical Studies

June 3, 2022 • By Vanessa Caceres

Remission Definitions in RA: Common Questions & Implications for Clinical Practice

May 5, 2022 • By Samantha C. Shapiro, MD

DNA Methylation Profiles May Shed Light on the Evolution of Arthritis in Patients

April 26, 2022 • By Lara C. Pullen, PhD

Case Report: Intermittent Fevers in a Patient with pJIA

April 15, 2022 • By Osman Bhatty, MD, Dale Kobrin, MD, Lauren Mathos, DO, Nazia Khatoon, MD, Yazan Samhouri, MD, Naga Sai Krishna Patibandla, MD, & Mary Chester Wasko, MD, MSc

The Power of Power Doppler: Ultrasound Imaging in RA

March 23, 2022 • By Jason Liebowitz, MD

Rheumatoid Arthritis Resource Center